[Differential diagnosis of disseminated lesions of the lungs].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to K A Turkebaeva.
Explore the source record for details and available documents.
In vitro destruction of carboxymethylcephades (CMC) polymer, its based polymer isoniazid produced, and the in vivo remedial and long effect of the latter on a tuberculous process were studied. It was found that a polymer isoniazid in blood plasma gradually degraded by 80% within 5-6 days. The experiments on animals demonstrated a minimum reactive action of CMC capable of gradually biodegrading in the tissues. A possible treatment of tuberculosis with a polymer isoniazid administered once every week is shown.
The results of treating 67 patients with postresection tuberculous empyema of the pleura and bronchial fistulas are presented. The complex treatment included courses of hyperbaric oxygenation. The treatment procedure is described. Closure of the bronchial fistula and decrease in the fistula diameter were observed in 23 (33.8 per cent) and 16 (24.5 per cent) patients, respectively. No closure of the bronchial fistula in 41.7 per cent of the patients was recorded. Increased erythropoiesis, decreased leukocytosis and higher leukocyte counts, retarded ESR, lower contents of transaminases, increased inhibition of leukocyte migration, lower levels of immunoglobulin E and fewer numbers of immune complexes circulating in blood were revealed.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.